How much could a microbicide's sexually transmitted infection efficacy contribute to reducing HIV risk and the level of condom use needed to lower risk? Model estimates

Sexually Transmitted Infections

Volumn 85, Issue 4, 2009, Pages 276-282

  Foss, A M ^a   Vickerman, P T ^a   Alary, M ^b   Watts, C H ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MICROBICIDE; SPERMICIDAL AGENT;

ARTICLE; BACTERIAL TRANSMISSION; CONDOM; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROSTITUTION; RISK REDUCTION; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE;

ANTI-INFECTIVE AGENTS; BENIN; CONDOMS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MODELS, THEORETICAL; PREVALENCE; PROSTITUTION; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; TREATMENT OUTCOME;

EID: 68249086598     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sti.2008.032458     Document Type: Article

References (41)

1. Global Campaign for Microbicides, Alliance for Microbicide Development. Product pipeline. September 2008. http://www.global-campaign.org/clientfiles/ FS14- AllianceProductPipeline[E]Sept08.pdf (accessed 10 Sept 2008).
2. Zeitlin L, Whaley KJ. Microbicides for preventing transmission of genital herpes. Herpes 2002;9:4-9. (Pubitemid 37489855)
3. De Clercq E. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin Microbiol Rev 2003;16:569-596 (Pubitemid 37296550)
4. Vickerman P, Watts C, Delany S, et al. The importance of context: model projections on how microbicide impact could be affected by the underlying epidemiologic and behavioral situation in 2 African settings. Sex Transm Dis 2006;33:397-405. (Pubitemid 43833029)
5. Heise L. Topical microbicides: new hope for STI/HIV prevention: Center for Health and Gender Equity (CHANGE) 1999. http://www.genderhealth.org/ (accessed June 2009).
6. Foss AM, Vickerman PT, Heise L, et al. Shifts in condom use following microbicide introduction: should we be concerned? AIDS 2003;17:1227-1237
7. Vickerman P, Foss A, Watts C. Using modeling to explore the degree to which a microbicide's sexually transmitted infection efficacy may contribute to the HIV effectiveness measured in phase 3 microbicide trials. J Acquir Immune Defic Syndr 2008;48:460-467
8. Lowndes CM, Alary M, Gnintoungbe CA, et al. Management of sexually transmitted diseases and HIV prevention in men at high risk: targeting clients and non-paying sexual partners of female sex workers in Benin. AIDS 2000;14:2523-2534 (Pubitemid 30840044)
9. Pinkerton SD, Abramson PR. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med 1997;44:1303-1312 (Pubitemid 27186886)
10. Alary M, Mukenge-Tshibaka L, Bernier F, et al. Decline in the prevalence of HIV and sexually transmitted diseases among female sex workers in Cotonou, Benin, 1993-1999. AIDS 2002;16:463-470
11. Lowndes CM, Alary M, Meda H, et al. Role of core and bridging groups in the transmission dynamics of HIV and STIs in Cotonou, Benin, West Africa. Sex Transm Infect 2002;78(Suppl 1):i69-77. (Pubitemid 34548002)
12. Royce RA, Sena A, Cates W Jr, et al. Sexual transmission of HIV. N Engl J Med 1997;336:1072-1078
13. Boily MC, Baggaley RF, Wang L, et al. The risk of HIV-1 infection per sexual contact in absence of antiretroviral therapy: a systematic review and meta-analysis of observational studies. Proceedings of the 17th International Society for Sexually Transmitted Diseases Research; 29 July-1 August 2007, Seattle, Washington, USA [Abstract O-058].
14. Vickerman P, Watts C, Alary M, et al. Sensitivity requirements for the point of care diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in women. Sex Transm Infect 2003;79:363-367 (Pubitemid 37330301)
15. Holmes KK, Johnson DW, Trostle HJ. An estimate of the risk of men acquiring gonorrhea by sexual contact with infected females. Am J Epidemiol 1970;91:170-174
16. Hooper RR, Reynolds GH, Jones OG, et al. Cohort study of venereal disease. 1: The risk of gonorrhoea transmission from infected women to men. Am J Epidemiol 1978;108:136-144
17. Kretzschmar M, Welte R, van den Hoek A, et al. Comparative model-based analysis of screening programs for Chlamydia trachomatis infections. Am J Epidemiol 2001;153:90-101. (Pubitemid 32042160)
18. Lycke E, Lowhagen GB, Hallhagen G, et al. The risk of transmission of genital Chlamydia trachomatis infection is less than that of genital Neisseria gonorrhoeae infection. Sex Transm Dis 1980;7:6-10. (Pubitemid 10026057)
19. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921-929
20. Pilcher CD, Price MA, Hoffman IF, et al. Frequent detection of acute primary HIV infection in men in Malawi. AIDS 2004;18:517-524
21. Bollinger RC, Brookmeyer RS, Mehendale SM, et al. Risk factors and clinical presentation of acute primary HIV infection in India. JAMA 1997;278:2085-2089
22. Pilcher CD, Tien HC, Eron JJ Jr, et al. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004;189:1785-1792
23. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis 2001;28:579-597
24. Sexton J, Garnett G, Rottingen JA. Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection. Sex Transm Dis 2005;32:351-357 (Pubitemid 40727179)
25. Korenromp EL, Sudaryo MK, de Vlas SJ, et al. What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? Int J STD AIDS 2002;13:91-101.
26. Vickerman P, Watts C, Peeling RW, et al. Modelling the cost effectiveness of rapid point of care diagnostic tests for the control of HIV and other sexually transmitted infections among female sex workers. Sex Transm Infect 2006;82:403-412 (Pubitemid 44578295)
27. Golden MR, Schillinger JA, Markowitz L, et al. Duration of untreated genital infections with Chlamydia trachomatis: a review of the literature. Sex Transm Dis 2000;27:329-337 (Pubitemid 30439547)
28. Buve A, Weiss HA, Laga M, et al. The epidemiology of gonorrhoea, chlamydial infection and syphilis in four African cities. AIDS 2001;15(Suppl 4):S79-88. (Pubitemid 32913007)
29. Wi T, Ramos ER, Steen R, et al. STI declines among sex workers and clients following outreach, one time presumptive treatment, and regular screening of sex workers in the Philippines. Sex Transm Infect 2006;82:386-391 (Pubitemid 44578292)
30. Rou K, Wu Z, Sullivan SG, et al. A five-city trial of a behavioural intervention to reduce sexually transmitted disease/HIV risk among sex workers in China. AIDS 2007;21(Suppl 8):S95-101.
31. Wang H, Wang N, Chen RY, et al. Prevalence and predictors of herpes simplex virus type 2 infection among female sex workers in Yunnan Province, China. Int J STD AIDS 2008;19:635-639
32. Quinn TC, Gaydos C, Shepherd M, et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA 1996;276:1737-1742 (Pubitemid 26423966)
33. Karmon E, Potts M, Getz WM. Microbicides and HIV: help or hindrance? J Acquir Immune Defic Syndr 2003;34:71-75
34. Smith RJ, Bodine EN, Wilson DP, et al. Evaluating the potential impact of vaginal microbicides to reduce the risk of acquiring HIV in female sex workers. AIDS 2005;19:413-421
35. Alary M, Lowndes CM, Guedeme A, et al. Scaling up prevention interventions for female sex workers in Benin: impact on HIV and STI prevalence. Proceedings of the 17th International Society for Sexually Transmitted Diseases Research; 29 July-1 August 2007, Seattle, Washington, USA [Abstract O-090].
36. Lowndes CM, Alary M, Labbe AC, et al. Interventions among male clients of female sex workers in Benin, West Africa: an essential component of targeted HIV preventive interventions. Sex Transm Infect 2007;83:577-581
37. Vu Nguyen T, Van Khuu N, Thi Le TT, et al. Sexually transmitted infections and risk factors for gonorrhea and chlamydia in female sex workers in Soc Trang, Vietnam. Sex Transm Dis 2008;35:935-940
38. Xu JJ, Wang N, Lu L, et al. HIV and STIs in clients and female sex workers in mining regions of Gejiu City, China. Sex Transm Dis 2008;35:558-565
39. Foss AM, Watts CH, Vickerman PT, et al. The importance of a microbicide's STI-efficacy in reducing HIV-risk and its affect on the reduction in condom use that can be tolerated following product introduction: model projections. Proceedings of the 17th International Society for Sexually Transmitted Diseases Research; 29 July-1 August 2007, Seattle, Washington, USA [Abstract 636].
40. Desai K, Boily MC, Garnett GP, et al. The role of sexually transmitted infections in male circumcision effectiveness against HIV - insights from clinical trial simulation. Emerg Themes Epidemiol 2006;3:19. (Pubitemid 46127300)
41. Chen FH. The impact of microbicides and changes in condom usage on HIV prevalence in men and women. AIDS 2006;20:1551-1553